http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2550105-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aff6633139e8f79659a0587cc38a6c07
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L33-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-1807
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02B1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L33-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-18
filingDate 2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a19eae01161d613538b17375b87f4042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b71c41df83893f807d37a5411860bca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16e6d40edf3060debda018af18afa3bd
publicationDate 2016-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2550105-B2
titleOfInvention Contact lenses for allergic conjunctivitis
abstract Contact lenses for allergic conjunctivitis. The present invention relates to hydrogels, release systems and optical devices suitable for the treatment or prevention of allergic conjunctivitis, in particular, seasonal allergic conjunctivitis. The hydrogels of the invention are useful in soft contact lenses, and for loading antihistamine active ingredients such as olopatadine, ketotifen or azelastine in an amount sufficient to elicit an adequate efficacy response.
priorityDate 2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2267

Total number of triples: 32.